INTRODUCTION
Natural products, whether in the form of extracts, isolated substances, or synthetic and semisynthetic compounds, have been evaluated for their utility in medicine, the food industry, and agriculture (e.g., as pest control agents). Their sources are not limited to higher plants, but include mosses, fungi, algae, and lichens-all of them producing an abundance of bioactive substances. In lichens, the acetate-polymalonate route yields phenolic compounds (depsides, depsidones, quinones, anthraquinones, xanthones, dibenzofurans, usnic acids, and other products). Many of these compounds have been evaluated for their activity as antimicrobials, against a wide range of bacteria and fungi; as antitumor agents, inhibiting growth in a large panel of tumor cells; as antivirals, inhibiting replication of viruses, including HIV; and as inhibitors of enzymes such as 5-lipoxygenase, protein tyrosine phosphatase, α-glucosidase, and aldose reductase; among many other activities investigated [1] [2] [3] .
Despite the marked activity exhibited by many lichen compounds, few have been evaluated for mutagenic or genotoxic properties, crucial for their safe use as drugs or in other applications. In an early investigation, Shibamoto and Wei [4] evaluated the mutagenicity of usnic, physodalic, and physodic acids. More recently, usnic, diffractaic, olivetoric, and psoromic acids have been investigated for their mutagenic and genotoxic potential [5] [6] [7] [8] [9] [10] .
The wing somatic mutation and recombination test (SMART) using Drosophila melanogaster was developed to detect loss of heterozygosity in suitable gene markers that express detectable phenotypes in wing cells. Rapid and inexpensive, the method quantifies, in an unambiguous and highly reproducible manner, the recombinogenic and mutagenic potential of chemical and physical agents [11, 12] . Two crosses-namely, standard (ST) and high-bioactivation (HB)-are typically used [13] . The ST cross, obtained from strains expressing basal levels of the metabolizing cytochrome P450 enzyme Cyp6A2, is employed to detect direct-acting genotoxins. The HB cross, obtained from strains expressing high levels of Cyp6A2, is used to detect indirect-acting genotoxins that exert their genotoxic activity only when metabolized [13, 14] .
The present study employed the SMART assay to evaluate the genotoxic and antigenotoxic activities of protocetraric, hypostictic, psoromic, and salazinic acids.
MATERIAL AND METHODS

General experimental procedures
TLC was performed on pre-coated silica gel 60 GF 254 plates (0.20 mm, Macherey-Nagel) and the spots were visualized by spraying the plates with a 10% sulfuric acid/methanol solution, followed by heating. Nuclear magnetic resonance (NMR) spectra were taken on a Bruker DPX-300 spectrometer using the solvent as an internal reference. Melting points were recorded on a Uniscience do Brasil 498 apparatus. 
Plant collection and extract preparation
jamaicensis).
Thalli of P. dilatatum, P. cetratum, P. sphaerospora, and U. jamaicensis were separately powdered and extracted with chloroform (2×), followed by acetone (3×), at room temperature, and subsequently concentrated in vacuo. The concentrated acetone extracts were then treated with a small volume of acetone in an ice bath and centrifuged. This procedure was repeated until a purified compound was obtained from each lichen. Protocetraric acid was obtained from P. dilatatum, hypostictic acid from P. sphaerospora, psoromic acid from U. jamaicensis, and salazinic acid from P. cetratum. The structures of these compounds were confirmed by NMR spectra (Figures S1-S9, Supplementary Material) and were concordant with the literature [15] [16] [17] .
Genotoxic activity: somatic mutation and recombination test (SMART)
The SMART assay with D. melanogaster was performed according to the methodology described by Fernandes et al. [18] . Three strains were used for cross breeding: (1) the "multiple wing hairs" ("mwh") strain, of mwh/mwh genetic constitution; (2) 34e and Bd S genetic constitution. This last strain inherits chromosomes 1 and 2 from the Oregon R (R) line (which is DDT resistant), carrying genes responsible for a high level of metabolizing enzymes of P(CYP)6 A2-type cytochrome [13] . Two crossings were performed between these strains: (a) the standard (ST) cross, from "mwh" males and "flare-3" virgin females [19] , and (b) the HB cross, from "mwh" males and "ORR; flare-3" virgin females [13] . The chi-squared test was employed to interpret the toxicity assay. Results were considered statistically significant when p < 0.05.
Statistical analysis
For each treatment, the frequencies of each type of spot (single small, single large, or twin) and the total frequency of spots per fly, for each treatment, were compared in pairs (negative control versus compounds; DXR alone versus compounds + DXR), in accordance with the multiple-decision procedure proposed by Frei and Würgler [20] , allowing four possible diagnoses: positive, negative, inconclusive, or weakly positive. The relative frequencies of each group were compared using Kastenbaum and Bowman's conditional binomial test [21] at a significance level of 5%. However, since false positive results can occur, all final weakly positive results were analyzed with the non-parametric U-test [22] . The recombination frequency (FR) was calculated as FR = 1 -FM.
RESULTS AND DISCUSSION
The SMART assay was performed to evaluate the genotoxic activities of protocetraric, hypostictic, psoromic, and salazinic acids (Figure 1 for HB crosses) (Figure 2 Similar genotoxicity levels for ST and HB crosses indicate that the enzyme system involved in cellular detoxification via cytochrome P450 does not interfere with the genotoxic effect of compounds on somatic cells of D. melanogaster [24] .
The compounds were evaluated not only for their ability to prevent or induce damage in genetic material when employed per se, but also for their ability to prevent DNA damage when administered in association with DXR-an antineoplastic anthracycline antibiotic that damages DNA by interacting with cytosine and guanine, leading to formation of DNA adducts, which may cause sister chromatid exchanges, chromosome aberrations, and interaction with topoisomerase II, preventing religation of double strands, with permanent DNA damage and subsequent non-homologous recombination events [25] . In addition, DXR generates radicals and oxidative stress, facilitating lipid peroxidation and ultimately inflicting oxidative damage to DNA [26] . (Tables S1-S8 , Supplementary Material). Again, a consistent pattern was observed for all four acids, with 72-100% (mostly >80%) inhibition of mutation events caused by DXR in descendants of ST and HB crosses. Hypostictic acid inhibited mutagenic events by 100% both in the ST cross, when employed at 3.0 mmol L -1 , and the HB cross, when used at 1.5 mmol L -1 and higher concentrations. Despite their antimutagenic activity, none of the compounds evaluated had significant influence on DXR-induced recombination (Tables S1-S8 , Supplementary Material). As revealed in previous studies using the SMART assay, the principal mutational contribution of DXR was related to its ability to induce recombination. DNA changes caused by chemical compounds can trigger a complex carcinogenesis process. In normal cells carrying mutations in malignant genes, loss of heterozygosity by mitotic recombination may unchain a neoplastic mechanism. Loss of a functional copy of a heterozygous tumor suppressor gene represents an important step during neoplastic transformation [27] . Furthermore, mutations that inactivate tumor suppressor genes or alter expression of oncogenes may cause malignant transformation [28] . The compounds evaluated exhibited noteworthy biological activities and elucidating their mutagenic profiles paves the way for their future use as protective agents against mutagenic events.
CONCLUSION
Protocetraric, hypostictic, psoromic, and salazinic acids isolated from Brazilian lichens exhibited antigenotoxic activity when tested on D. melanogaster cells, significantly reducing genetic damage caused by DXR. The antibiotic and antitumor activities of these compounds lend them for use in pharmaceutical applications, considering the proven safety of these substances (absence of DNA damage).
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